Lung Cancer Immunotherapy: Improving Patient Outcomes Across the Disease Continuum

Download All
Gain expert insights on best practices for incorporating immune checkpoint inhibitor therapy for patients with NSCLC in this comprehensive educational program, including an on-demand webcast of a CCO live symposium along with downloadable slidesets and a ClinicalThought commentary with expert answers to audience questions from the live event.
Julie R. Brahmer, MD
Zofia Piotrowska, MD, MHS
person default
Jarushka Naidoo, MB BCH BAO, MHS

Downloadable Slidesets

Download this slideset from a live CCO symposium for an overview of the key data on immunotherapy options for patients with early-stage resectable and stage III unresectable NSCLC.

Zofia Piotrowska, MD, MHS Released: November 10, 2022

Download this slideset from a live CCO symposium with key data on the changing landscape for the use of immunotherapy in advanced or metastatic NSCLC.

Julie R. Brahmer, MD Released: November 10, 2022

Download this slideset from a live CCO symposium for expert perspective on optimal use of immunotherapy in various patient populations, including those with CNS metastases or poor performance status, along with highlights of emerging data on immunotherapy combination regimens in clinical trials.

person default Jarushka Naidoo, MB BCH BAO, MHS Released: November 10, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Regeneron Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings